TC BIOPHARM (HOLDINGS) PLC — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3bfaddf7-95a5-43ca-8bb8-1e9147416bf6/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | — | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-009445 |
| FY 2023 | — | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-012486 |
| FY 2022 | — | 2022-01-01 – 2022-12-31 | evidence 0001493152-24-012486 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).